One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The two new locally acquired cases are from the same area where the first case was reported last week. In other state news: vaccine hesitancy and the Minnesota measles outbreak; an "epidemic" of ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...

A pair of recent studies highlighted two potential new uses for metformin, a Type 2 diabetes drug. One points to the drug possibly helping people living with HIV, and another shows the drug could ...

Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

HIV PrEP medications are usually prescribed by PCPs; however, adherence to PrEP varies by clinician specialty due to the different populations served.

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...